
In the pharmaceutical industry, the main communication risk is no longer just that a message goes unnoticed. The real challenge is that a poorly calibrated piece triggers regulatory questions, competitor objections or damages the organization’s credibility. In markets such as Peru and Mexico, where scrutiny of the communication of products…
Tell us about your challenge, and we will be in touch shortly.